ARCHIVES

Brenner To Leave Breast Cancer Action

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI, NEI Announce Interest In Grants On Ocular, Melanoma

November 21, 1980

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990